Management of IRIS
Summary
- Diagnosis and treatment of patients with IRIS should be managed by a specialist
- Primary care providers should be aware that patients with low baseline CD4+ cell counts with a robust response to ART are at increased risk of IRIS
- ART should not be delayed in patients for whom it is indicated, although guidance for patients with cryptococcal disease is evolving
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content
Keywords: IRIS, Primary Care Considerations